Soluble Toll-like Receptor 4: A New Player in Subclinical Inflammation and Malnutrition in Hemodialysis Patients

Journal of Renal Nutrition - Tập 28 - Trang 259-264 - 2018
Pasquale Esposito1, Edoardo La Porta1, Maria Antonietta Grignano1, Daniela Verzola2, Samantha Milanesi2, Francesca Ansaldo2, Marilena Gregorini1, Carmelo Libetta1, Giacomo Garibotto2, Teresa Rampino1
1Department of Nephrology, Dialysis and Transplantation, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy
2Department of Internal Medicine, University of Genoa and IRCCS Azienda Ospedaliera Universitaria San Martino-IST, Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy

Tài liệu tham khảo

Tonelli, 2006, Chronic kidney disease and mortality risk: a systematic review, J Am Soc Nephrol, 17, 2034, 10.1681/ASN.2005101085 Kendrick, 2008, Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease, Nat Clin Pract Nephrol, 4, 672, 10.1038/ncpneph0954 Libetta, 2011, Oxidative stress and inflammation: implications in uremia and hemodialysis, Clin Biochem, 44, 1189, 10.1016/j.clinbiochem.2011.06.988 Choi, 2012, The malnutrition-inflammation-depression-arteriosclerosis complex is associated with an increased risk of cardiovascular disease and all-cause death in chronic hemodialysis patients, Nephron Clin Pract, 122, 44, 10.1159/000348509 Akchurin, 2015, Update on inflammation in chronic kidney disease, Blood Purif, 39, 84, 10.1159/000368940 Kooman, 2017, Inflammation and premature aging in advanced chronic kidney disease, Am J Physiol Renal Physiol, 313, F938, 10.1152/ajprenal.00256.2017 Stenvinkel, 2005, IL-10, IL-6, and TNFalpha: central factors in the altered cytokine network of uremia–the good, the bad, and the ugly, Kidney Int, 67, 1216, 10.1111/j.1523-1755.2005.00200.x Cook, 2004, Toll-like receptors in the pathogenesis of human disease, Nat Immunol, 5, 975, 10.1038/ni1116 Beutler, 2009, TLRs and innate immunity, Blood, 113, 1399, 10.1182/blood-2008-07-019307 Kawasaki, 2014, Toll-like receptor signaling pathways, Front Immunol, 5, 461, 10.3389/fimmu.2014.00461 Rosadini, 2017, Early innate immune responses to bacterial LPS, Curr Opin Immunol, 44, 14, 10.1016/j.coi.2016.10.005 Jaresova, 2007, Kinetics of Toll-like receptor-4 splice variants expression in lipopolysaccharide-stimulated antigen presenting cells of healthy donors and patients with cystic fibrosis, Microbes Infect, 9, 1359, 10.1016/j.micinf.2007.06.009 Iwami, 2000, Cutting edge: naturally occurring soluble form of mouse Toll-like receptor 4 inhibits lipopolysaccharide signaling, J Immunol, 165, 6682, 10.4049/jimmunol.165.12.6682 Zunt, 2009, Soluble forms of Toll-like receptor 4 are present in human saliva and modulate tumour necrosis factor-alpha secretion by macrophage-like cells, Clin Exp Immunol, 156, 285, 10.1111/j.1365-2249.2009.03854.x Ten Oever, 2014, The discriminative capacity of soluble Toll-like receptor (sTLR)2 and sTLR4 in inflammatory diseases, BMC Immunol, 15, 55, 10.1186/s12865-014-0055-y Martin-Rodriguez, 2015, TLR4 and NALP3 inflammasome in the development of endothelial dysfunction in uraemia, Eur J Clin Invest, 45, 160, 10.1111/eci.12392 Koc, 2011, Toll-like receptor expression in monocytes in patients with chronic kidney disease and haemodialysis: relation with inflammation, Nephrol Dial Transpl, 26, 955, 10.1093/ndt/gfq500 Mudaliar, 2014, Role of Toll-like receptors in diabetic nephropathy, Clin Sci (Lond), 126, 685, 10.1042/CS20130267 Anderberg, 2017, Physiological aspects of Toll-like receptor 4 activation in sepsis-induced acute kidney injury, Acta Physiol (Oxf), 219, 573, 10.1111/apha.12798 Verzola, 2017, Toll-like receptor 4 signalling mediates inflammation in skeletal muscle of patients with chronic kidney disease, J Cachexia Sarcopenia Muscle, 8, 131, 10.1002/jcsm.12129 Broers, 2015, Body composition in dialysis patients: a functional assessment of bioimpedance using different prediction models, J Ren Nutr, 25, 121, 10.1053/j.jrn.2014.08.007 Korevaar, 2004, Effect of an increase in C-reactive protein level during a hemodialysis session on mortality, J Am Soc Nephrol, 15, 2916, 10.1097/01.ASN.0000143744.72664.66 Herselman, 2010, Relationship between body mass index and mortality in adults on maintenance hemodialysis: a systematic review, J Ren Nutr, 20, 281, 10.1053/j.jrn.2010.03.010 Ikizler, 2008, Nutrition, inflammation and chronic kidney disease, Curr Opin Nephrol Hypertens, 17, 162, 10.1097/MNH.0b013e3282f5dbce Memoli, 2007, Inflammation may modulate IL-6 and C-reactive protein gene expression in the adipose tissue: the role of IL-6 cell membrane receptor, Am J Physiol Endocrinol Metab, 293, E1030, 10.1152/ajpendo.00697.2006 Han, 2011, Serum myostatin levels and grip strength in normal subjects and patients on maintenance haemodialysis, Clin Endocrinol (Oxf), 75, 857, 10.1111/j.1365-2265.2011.04120.x Rao, 2005, Plasma interleukin-6 predicts cardiovascular mortality in hemodialysis patients, Am J Kidney Dis, 45, 324, 10.1053/j.ajkd.2004.09.018 Fukasawa, 2017, Lower thigh muscle mass is associated with all-cause and cardiovascular mortality in elderly hemodialysis patients, Eur J Clin Nutr, 71, 64, 10.1038/ejcn.2016.186 Meert, 2009, Effective removal of protein-bound uraemic solutes by different convective strategies: a prospective trial, Nephrol Dial Transplant, 24, 562, 10.1093/ndt/gfn522 Lin, 2002, Improved iron utilization and reduced erythropoietin resistance by on-line hemodiafiltration, Blood Purif, 20, 349, 10.1159/000063103 Knezevic, 2012, Influence of dialysis modality and membrane flux on quality of life in hemodialysis patients, Ren Fail, 34, 849, 10.3109/0886022X.2012.684555 Davenport, 2016, Higher convection volume exchange with online hemodiafiltration is associated with survival advantage for dialysis patients: the effect of adjustment for body size, Kidney Int, 89, 193, 10.1038/ki.2015.264 Leurs, 2013, Effects of hemodiafiltration on uremic inflammation, Blood Purif, 35 Suppl 1, 11, 10.1159/000346359 Esposito, 2017, Modulation of Myostatin/Hepatocyte Growth Factor balance by different hemodialysis modalities, Biomed Res Int, 2017, 7635459 Liew, 2005, Negative regulation of toll-like receptor-mediated immune responses, Nat Rev Immunol, 5, 446, 10.1038/nri1630 Hyakushima, 2004, Interaction of soluble form of recombinant extracellular TLR4 domain with MD-2 enables lipopolysaccharide binding and attenuates TLR4-mediated signaling, J Immunol, 173, 6949, 10.4049/jimmunol.173.11.6949 Memoli, 2005, In vivo modulation of soluble “antagonistic” IL-6 receptor synthesis and release in ESRD, J Am Soc Nephrol, 16, 1099, 10.1681/ASN.2004080628 Esposito, 2012, Soluble CD40 as a modulator of CD40 pathway, Immunol Lett, 147, 85, 10.1016/j.imlet.2012.06.003 Mulay, 2016, Necroinflammation in kidney disease, J Am Soc Nephrol, 27, 27, 10.1681/ASN.2015040405 Santoni, 2015, Toll like receptors and pancreatic diseases: from a pathogenetic mechanism to a therapeutic target, Cancer Treat Rev, 41, 569, 10.1016/j.ctrv.2015.04.004 Jia, 2014, TLR4 signaling: a potential therapeutic target in ischemic coronary artery disease, Int Immunopharmacol, 23, 54, 10.1016/j.intimp.2014.08.011 Liu, 2014, Protective effect of resveratrol against IL-1beta-induced inflammatory response on human osteoarthritic chondrocytes partly via the TLR4/MyD88/NFkappaB signaling pathway: an “in vitro study”, Int J Mol Sci, 15, 6925, 10.3390/ijms15046925 Souza, 2015, TLR4 mutant mice are protected from renal fibrosis and chronic kidney disease progression, Physiol Rep, 3, e12558, 10.14814/phy2.12558 Peri, 2014, Toll-like Receptor 4 (TLR4) modulation by synthetic and natural compounds: an update, J Med Chem, 57, 3612, 10.1021/jm401006s